Last Price
2.90
Today's Change
+0.11 (3.94%)
Day's Change
2.73 - 3.05
Trading Volume
1,759,859
Market Cap
380 Million
Shares Outstanding
131 Million
Avg Volume
1,746,723
Avg Price (50 Days)
3.60
Avg Price (200 Days)
5.00
PE Ratio
-1.41
EPS
-2.06
Earnings Announcement
06-Mar-2025
Previous Close
2.79
Open
2.76
Day's Range
2.73 - 3.05
Year Range
2.56 - 9.8
Trading Volume
2,315,230
1 Day Change
3.94%
5 Day Change
-0.34%
1 Month Change
-2.36%
3 Month Change
-24.28%
6 Month Change
-51.59%
Ytd Change
-66.89%
1 Year Change
-66.89%
3 Year Change
-81.13%
5 Year Change
-81.13%
10 Year Change
-81.13%
Max Change
-81.13%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.